Sacituzumab govitecan is an antibody-drug concatenation (ADC) containing a humanized anti-trophoblast cell surface antigen 2 (TROP-2) antibody as well as the topoisomerase I inhibitor SN-38It delivers high concentrations of SN-38 to tumors and can be used in studies related to triple-negative breast cancer.
Reinheit:
>99.0%
CAS Nummer:
[1491917-83-9]
Target-Kategorie:
ADC Linker
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten